Sun Pharma, Lupin recall drugs in US over manufacturing issues: USFDA

Sun Pharma, Lupin recall drugs in US over manufacturing issues: USFDA

Leading drugmakers Sun Pharma and Lupin have recalled their products in the US market over manufacturing issues, as per the US Food and Drug Administration (USFDA). Mumbai-based Sun Pharmaceutical Industries is recalling 96,192 bottles of Liothyronine Sodium Tablets in the US that are used to treat an underactive thyroid. The company is recalling the lot due to "failed impurities/degradation specifications", the USFDA stated.US Food and Drug Administration stated that Mumbai-based Lupin is also recalling an unspecified number of penicillamine tablets in the US.


The medication is used to treat rheumatoid arthritis and Wilson's disease. Baltimore-based Lupin Pharmaceuticals Inc, a unit of the company, is recalling the affected lot that was produced at the drugmaker's Nagpur-based facility.


Lupin Q2 results: Net profit jumps 277% to ₹490 crore


As per the USFDA, the company is recalling the affected lot due to "failed dissolution specifications".


The company initiated the Class II nationwide (US) voluntary recall on November 22.


As per the USFDA, a class II recall is initiated in a situation in which the use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.Lupin's Madhya Pradesh facility receives EIR from USFDA


The Indian pharmaceutical industry is the third largest in the world by volume. The US is the world's largest market for pharmaceutical products.

Optimize Your trial insights with Clival Database.

Are you exhausted from the uncertainty of trial insights pricing? Clival Database ensures the clarity in the midst of the global scenario for clinical trials to you.

Clival Database is one of the best databases that offers an outstanding number of clinical trial data in terms of 50,000+ molecules and from primary regulatory markets as well as new entrants like Indian and Chinese markets.

With Clival, you get accurate positioning of historical sales data, patent database, company profiling, safety & efficacy, and prediction of launch of new innovative molecules helping you to align your research and driving down the cost.

To add value, we further break down our analytics for you so that improving your operational effectiveness; optimizing your clinical trials; and offering you accurate and high-quality data at lowest possible prices becomes possible.

Elevate your trial success rate with the cutting-edge insights from Clival database.

Check it out today and make more informed sourcing decisions! Learn More!